http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002169356-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-04 |
| filingDate | 2001-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7c0c401f948a0ea9f46c43f8bc4fde3 |
| publicationDate | 2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002169356-A1 |
| titleOfInvention | Method of treating the symptoms of scleroderma |
| abstract | Using to a first and second advantage for scleroderma a known treatment of a high frequency electromagnetic field, the first advantage being that the rest period between the pulses is approximately twenty-four times as great as the duration of each pulse, so that any heat that might be accumulated in the patient during the occurrence of the pulse has many times longer for its dissipation, thereby providing a treatment which is not harmful to the patient, and now a second advantage that it can be applied to an exact location of the patient, wherein the site of the scleroderma which can visually determined is correlated to the exact site of the applied treatment. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010049262-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7563224-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008064272-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008125617-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008064272-A3 |
| priorityDate | 2001-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 |
Total number of triples: 18.